Sharon Anderson
Vice President, Scientific Affairs Alliance for Regenerative Medicine
Sharon Anderson is Vice President for Scientific Affairs at the Alliance for Regenerative Medicine (ARM). She joined the organization in 2025, bringing more than 20 years of leadership experience in cell therapy, immuno-oncology, and manufacturing operations. Her expertise spans research and development, manufacturing, technology transfer, and advanced analytical methods. At ARM, Sharon leads the 2026 CAR-T Access Coalition and helps drive cross-sector engagement among scientific leaders to shape best practices and advance the CGT field.
Seminars
Tuesday 15th September 2026
Panel Discussion: Navigating Regulatory GMP Expectations to De-Risk Development & Enable Market Access
12:00 pm
- Interpreting updated cell therapy GMP and advanced manufacturing technology expectations to leverage regulatory flexibility without compromising compliance
- Examining how evolving regulatory guidance influences clinical outcomes and commercialization pathways to align manufacturing quality with long-term market success
Wednesday 16th September 2026
Charting Regulatory Shifts in CGT: Decisions, Innovation & What’s Next
2:05 pm
- Summarizing trends in recent CGT FDA decisions
- Sharing new tools and platform technologies of interest at the FDA
- Diving into FDA trends and future direction
